# Correction: Ritlecitinib, a JAK3 /TEC inhibitor, modulates the markers of celiac autoimmunity in alopecia areata and vitiligo patients

**Authors:** Rok Seon Choung, Jyoti Ramakrishna, Vivek Pradhan, Brett King, Emma Guttman-Yassky, Elena Peeva, Joseph A. Murray

PMC · DOI: 10.1007/s00403-025-04136-8 · 2025-03-12

## Full-text entities

- **Genes:** TEC (tec protein tyrosine kinase) [NCBI Gene 7006] {aka PSCTK4}, JAK3 (Janus kinase 3) [NCBI Gene 3718] {aka JAK-3, JAK3_HUMAN, JAKL, L-JAK, LJAK}
- **Diseases:** vitiligo (MESH:D014820), celiac autoimmunity (MESH:D002446), alopecia areata (MESH:D000506)
- **Chemicals:** Ritlecitinib (MESH:C000614924)
- **Species:** Homo sapiens (human, species) [taxon 9606]

---
Source: https://tomesphere.com/paper/PMC11903507